LIFE Message Board Post 9269468 | aTyr Pharma Inc.
home / stock / life / life message board
dudelive
(investorshub)
Posted on: Mar/16/2021 21:33:24
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162604700
* * $LIFE Video Chart 03-16-2021 * *
News, Short Squeeze, Breakout and More Instantly...
-
Independent data and safety monitoring board (DSMB) recommends continuation of study without any modifications. Findings further support favorable safety profile of efzofitimod. SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or the “Compa...
-
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment in the second quarter of 2024. Ended the first quarter 2024 with $87.7 million in cash, cash equivalents, restricted cash and investments. SAN DIEGO, May 02, 2024 (GLOBE NEWS...
-
SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (NASDAQ:LIFE), a clinical stage biotechnology company engaged in the discovery a...